Capstone Investment Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Buy
6,300
+1,500
+31% +$323K ﹤0.01% 758
2025
Q4
$986K Sell
4,800
-2,000
-29% -$376K ﹤0.01% 869
2025
Q3
$1.07M Sell
6,800
-2,900
-30% -$448K ﹤0.01% 989
2025
Q2
$1.63M Sell
9,700
-17,400
-64% -$2.58M ﹤0.01% 711
2025
Q1
$3.73M Sell
27,100
-10,900
-29% -$1.39M 0.01% 528
2024
Q4
$4.49M Buy
38,000
+15,500
+69% +$1.81M 0.01% 590
2024
Q3
$2.49M Buy
22,500
+2,900
+15% +$303K 0.01% 664
2024
Q2
$1.93M Buy
19,600
+4,000
+26% +$408K 0.01% 733
2024
Q1
$1.75M Sell
15,600
-11,900
-43% -$1.28M 0.01% 843
2023
Q4
$2.77M Buy
27,500
+13,600
+98% +$1.35M 0.01% 719
2023
Q3
$1.21M Buy
13,900
+4,600
+49% +$416K 0.01% 917
2023
Q2
$880K Hold
9,300
﹤0.01% 916
2023
Q1
$702K Sell
9,300
-11,400
-55% -$860K ﹤0.01% 900
2022
Q4
$1.59M Hold
20,700
0.01% 779
2022
Q3
$1.38M Buy
20,700
+2,700
+15% +$171K 0.01% 906
2022
Q2
$941K Sell
18,000
-56,500
-76% -$3.21M ﹤0.01% 1047
2022
Q1
$4.22M Sell
74,500
-132,200
-64% -$7.08M 0.01% 764
2021
Q4
$10.6M Buy
206,700
+5,200
+3% +$255K 0.02% 582
2021
Q3
$9.97M Buy
201,500
+13,800
+7% +$749K 0.02% 623
2021
Q2
$10.7M Buy
187,700
+76,000
+68% +$4.44M 0.02% 518
2021
Q1
$6.79M Buy
111,700
+41,900
+60% +$2.31M 0.02% 566
2020
Q4
$3.74M Sell
69,800
-5,100
-7% -$265K 0.01% 685
2020
Q3
$3.52M Buy
74,900
+16,300
+28% +$836K 0.02% 611
2020
Q2
$3.06M Buy
58,600
+19,300
+49% +$995K 0.02% 575
2020
Q1
$1.88M Sell
39,300
-81,300
-67% -$4.22M 0.03% 543
2019
Q4
$6.1M Buy
120,600
+56,200
+87% +$2.9M 0.03% 486
2019
Q3
$3.04M Sell
64,400
-500
-0.8% -$22.8K 0.02% 608
2019
Q2
$3.06M Buy
64,900
+24,300
+60% +$1.12M 0.02% 616
2019
Q1
$1.96M Buy
40,600
+19,900
+96% +$997K 0.02% 611
2018
Q4
$923K Buy
20,700
+6,100
+42% +$318K 0.01% 642
2018
Q3
$788K Buy
+14,600
New +$747K 0.01% 670

Other funds holding CAH

Capstone Investment Advisors's CAH Position: Q1 2026 in Review

Capstone Investment Advisors increased its Cardinal Health (CAH) stake by 12% in Q1 2026, buying an estimated $67.8K and bringing the position to 2,923 shares worth $618K. The position accounts for ﹤0.01% of the portfolio, ranked #1044.

Capstone Investment Advisors first reported a position in CAH in Q3 2015 and has held it in 19 quarters since. The position peaked at $3.5M in Q3 2021. 1,429 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Capstone Investment Advisors held 2,923 shares of Cardinal Health worth $618K as of Q1 2026.
  • Capstone Investment Advisors bought 315 Cardinal Health shares in Q1 2026, an estimated $67.8K.
  • Cardinal Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1044 holding.
  • Capstone Investment Advisors first reported a position in Cardinal Health in Q3 2015 and has held it in 19 quarters since.
  • Capstone Investment Advisors's Cardinal Health position peaked at $3.5M in Q3 2021.
  • 1,429 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.